» Articles » PMID: 19147555

De Novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA

Overview
Journal Cancer Res
Specialty Oncology
Date 2009 Jan 17
PMID 19147555
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Spontaneous mouse models of cancer show promise to more accurately recapitulate human disease and predict clinical efficacy. Transgenic mice or viral vectors have been required to generate spontaneous models of glioma, a lethal brain tumor, because nonviral gene transfer is typically transient. To overcome this constraint, we used the Sleeping Beauty transposable element to achieve chromosomal integration of human oncogenes into endogenous brain cells of immunocompetent mice. Genetically engineered, spontaneous brain tumors were induced with plasmid DNA in a matter of weeks in three separate mouse strains. The phenotype of tumors was influenced by the combination of oncogenes delivered, resembling human astrocytoma or glioblastoma in the majority of cases. At least five different genes can be cotransfected simultaneously including reporters, allowing measurement of tumor viability by in vivo imaging. This model can accelerate brain tumor research in a variety of ways such as generation of "humanized" models for high throughput drug screening and candidate gene validation with exceptional speed and flexibility.

Citing Articles

High-efficiency magnetophoretic labelling of adoptively-transferred T cells for longitudinal Magnetic Particle Imaging.

Tay R, P L, Pang S, Low K, Tay H, Ho C Theranostics. 2024; 14(16):6138-6160.

PMID: 39431019 PMC: 11488102. DOI: 10.7150/thno.95527.


γ-Glutamylcyclotransferase is transcriptionally regulated by c-Jun and controls proliferation of glioblastoma stem cells through Notch1 levels.

Nose K, Taniguchi K, Fujita M, Moyama C, Mori M, Ishita M Cancer Gene Ther. 2024; 31(12):1831-1839.

PMID: 39394529 DOI: 10.1038/s41417-024-00835-y.


Role of scaffold proteins in the heterogeneity of glioblastoma.

Iyer V, Donahue J, Osman M Cell Commun Signal. 2024; 22(1):477.

PMID: 39375741 PMC: 11457365. DOI: 10.1186/s12964-024-01809-1.


Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma.

Zhu C, Chen X, Liu T, Cheng L, Cheng W, Cheng P Nat Commun. 2024; 15(1):8506.

PMID: 39353936 PMC: 11445535. DOI: 10.1038/s41467-024-52888-0.


Pre-Clinical Models for CAR T-Cell Therapy for Glioma.

Vandecandelaere G, Ramapriyan R, Gaffey M, Richardson L, Steuart S, Tazhibi M Cells. 2024; 13(17.

PMID: 39273050 PMC: 11394304. DOI: 10.3390/cells13171480.


References
1.
Gunther H, Schmidt N, PHILLIPS H, Kemming D, Kharbanda S, Soriano R . Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene. 2007; 27(20):2897-909. DOI: 10.1038/sj.onc.1210949. View

2.
Uhrbom L, Hesselager G, Nister M, Westermark B . Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 1998; 58(23):5275-9. View

3.
Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P . Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci. 2006; 26(25):6781-90. PMC: 6673823. DOI: 10.1523/JNEUROSCI.0514-06.2006. View

4.
Zhang C, Yadava P, Hughes J . Polyethylenimine strategies for plasmid delivery to brain-derived cells. Methods. 2004; 33(2):144-50. DOI: 10.1016/j.ymeth.2003.11.004. View

5.
Wu A, Oh S, Ericson K, Demorest Z, Vengco I, Gharagozlou S . Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Cancer Gene Ther. 2007; 14(6):550-60. DOI: 10.1038/sj.cgt.7701045. View